OBJECTIVES: To investigate maximum enhancement and visual map quality in cerebral perfusion computed tomography (PCT) with variation of iodine concentration of contrast media (CM). MATERIALS AND METHODS: Two groups of 45 patients each, underwent PCT with either 370 mg iodine/mL (30 mL; 6 mL/s) or 300 mg iodine/mL (40 mL; 8 mL/s) CM, respectively, and similar total iodine dose. Parenchymal and vascular enhancement as well as contrast-to-noise ratio of superior sagittal sinus was measured on PCT source images. PCT maps were rated visually with dichotomized scale for diagnostic quality. RESULTS: Enhancement and contrast-to-noise ratio of the superior sagittal sinus was significantly higher for the 370 mg iodine/mL protocol (P < 0.0002 and P < 0.007), whereas parenchymal enhancement was not significantly different. Diagnostic quality of PCT maps did not differ between both protocols (P < 0.557). CONCLUSIONS: PCT using 370 mg iodine/mL CM can be reliably performed with reduced injection rate and less total volume enabling smaller diameter of intravenous canula compared with 300 mg iodine/mL CM.
OBJECTIVES: To investigate maximum enhancement and visual map quality in cerebral perfusion computed tomography (PCT) with variation of iodine concentration of contrast media (CM). MATERIALS AND METHODS: Two groups of 45 patients each, underwent PCT with either 370 mg iodine/mL (30 mL; 6 mL/s) or 300 mg iodine/mL (40 mL; 8 mL/s) CM, respectively, and similar total iodine dose. Parenchymal and vascular enhancement as well as contrast-to-noise ratio of superior sagittal sinus was measured on PCT source images. PCT maps were rated visually with dichotomized scale for diagnostic quality. RESULTS: Enhancement and contrast-to-noise ratio of the superior sagittal sinus was significantly higher for the 370 mg iodine/mL protocol (P < 0.0002 and P < 0.007), whereas parenchymal enhancement was not significantly different. Diagnostic quality of PCT maps did not differ between both protocols (P < 0.557). CONCLUSIONS: PCT using 370 mg iodine/mL CM can be reliably performed with reduced injection rate and less total volume enabling smaller diameter of intravenous canula compared with 300 mg iodine/mL CM.